10:02 AM EST - BioWest Therapeutics Inc. : announced today the financial results for its three months ended July 31, 2010. For the quarter ended July 31, 2010, the Company reported a loss of $0.43 million or $(0.03) per share compared to a loss of $0.74 million or $(0.05) per share in the comparable quarter ended July 31, 2009. The $0.31 million decrease in the Q1/FY11 loss compared to the Q1/FY10 loss is principally due to a $0.28 million decline in operating expenses. BioWest Therapeutics Inc.
shares T.BWE are trading unchanged at $0.30.
